Literature DB >> 9279982

Rapid detection and identification of dengue viruses by polymerase chain reaction (PCR).

P T Yenchitsomanus1, P Sricharoen, I Jaruthasana, S N Pattanakitsakul, S Nitayaphan, J Mongkolsapaya, P Malasit.   

Abstract

A polymerase chain reaction (PCR) method using sets of newly designed primers for rapid detection and simultaneous identification of dengue virus serotypes was developed and tested. The test is based on two sets of primers specific within the envelope (E) and non-structural (NS1) regions of the dengue-virus genome. Two sets of universal primers that bind to two target sequences which are shared by all the four serotypes of the virus within the E and NS1 regions are used. The resulting products are further amplified by another pair of inner or nested universal primers, which also bind to another set of shared sequences within the E and NS1 regions, respectively. The nested PCR of both the E and NS1 regions can detect dengue virus of all the four serotypes at a sensitivity of 1 plaque forming unit (pfu) or less. For the identification of serotypes, a mixture of four pairs of serotype-specific primers, specific to the E region, was used. The primers have been designed to bind to serotype specific sequences within the regions flanked by the outer universal primers, and giving the amplified products of different sizes, each corresponds to one particular serotype (405 bp for Den1, 346 bp for Den2, 196 bp for Den3, and 143 bp for Den4). A protocol has been developed and successfully applied to detect dengue virus in cell-culture supernatants and patients sera. The technique is simple and rapid, capable of not only detecting the dengue virus but also identifying the serotypes of the virus in clinical specimens.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9279982

Source DB:  PubMed          Journal:  Southeast Asian J Trop Med Public Health        ISSN: 0125-1562            Impact factor:   0.267


  26 in total

1.  Specific IgM and IgG responses in primary and secondary dengue virus infections determined by enzyme-linked immunosorbent assay.

Authors:  A Sa-Ngasang; S Anantapreecha; A A-Nuegoonpipat; S Chanama; S Wibulwattanakij; K Pattanakul; P Sawanpanyalert; I Kurane
Journal:  Epidemiol Infect       Date:  2005-12-22       Impact factor: 2.451

2.  Human antibody responses after dengue virus infection are highly cross-reactive to Zika virus.

Authors:  Lalita Priyamvada; Kendra M Quicke; William H Hudson; Nattawat Onlamoon; Jaturong Sewatanon; Srilatha Edupuganti; Kovit Pattanapanyasat; Kulkanya Chokephaibulkit; Mark J Mulligan; Patrick C Wilson; Rafi Ahmed; Mehul S Suthar; Jens Wrammert
Journal:  Proc Natl Acad Sci U S A       Date:  2016-06-27       Impact factor: 11.205

3.  Secreted NS1 Protects Dengue Virus from Mannose-Binding Lectin-Mediated Neutralization.

Authors:  Somchai Thiemmeca; Chamaiporn Tamdet; Nuntaya Punyadee; Tanapan Prommool; Adisak Songjaeng; Sansanee Noisakran; Chunya Puttikhunt; John P Atkinson; Michael S Diamond; Alongkot Ponlawat; Panisadee Avirutnan
Journal:  J Immunol       Date:  2016-10-19       Impact factor: 5.422

4.  Functional Analysis of the Dengue Virus Genome Using an Insertional Mutagenesis Screen.

Authors:  Jeffrey W Perry; Yanhua Chen; Elizabeth Speliotes; Andrew W Tai
Journal:  J Virol       Date:  2018-03-14       Impact factor: 5.103

5.  Dengue virus RNA purification from human plasma: a comparison of two techniques.

Authors:  Raquel Spinassé Dettogni; Iúri Drumond Louro
Journal:  Mol Biol Rep       Date:  2010-12-15       Impact factor: 2.316

6.  Rapid and massive virus-specific plasmablast responses during acute dengue virus infection in humans.

Authors:  Jens Wrammert; Nattawat Onlamoon; Rama S Akondy; Guey C Perng; Korakot Polsrila; Anmol Chandele; Marcin Kwissa; Bali Pulendran; Patrick C Wilson; Orasri Wittawatmongkol; Sutee Yoksan; Nasikarn Angkasekwinai; Kovit Pattanapanyasat; Kulkanya Chokephaibulkit; Rafi Ahmed
Journal:  J Virol       Date:  2012-01-11       Impact factor: 5.103

7.  Microparticles provide a novel biomarker to predict severe clinical outcomes of dengue virus infection.

Authors:  Nuntaya Punyadee; Dumrong Mairiang; Somchai Thiemmeca; Chulaluk Komoltri; Wirichada Pan-Ngum; Nusara Chomanee; Komgrid Charngkaew; Nattaya Tangthawornchaikul; Wannee Limpitikul; Sirijitt Vasanawathana; Prida Malasit; Panisadee Avirutnan
Journal:  J Virol       Date:  2014-11-19       Impact factor: 5.103

8.  Typing of dengue viruses in clinical specimens and mosquitoes by single-tube multiplex reverse transcriptase PCR.

Authors:  E Harris; T G Roberts; L Smith; J Selle; L D Kramer; S Valle; E Sandoval; A Balmaseda
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

9.  B Cell Responses during Secondary Dengue Virus Infection Are Dominated by Highly Cross-Reactive, Memory-Derived Plasmablasts.

Authors:  Lalita Priyamvada; Alice Cho; Nattawat Onlamoon; Nai-Ying Zheng; Min Huang; Yevgeniy Kovalenkov; Kulkanya Chokephaibulkit; Nasikarn Angkasekwinai; Kovit Pattanapanyasat; Rafi Ahmed; Patrick C Wilson; Jens Wrammert
Journal:  J Virol       Date:  2016-05-27       Impact factor: 5.103

10.  Longitudinal Analysis of Antibody Cross-neutralization Following Zika Virus and Dengue Virus Infection in Asia and the Americas.

Authors:  Magelda Montoya; Matthew Collins; Wanwisa Dejnirattisai; Leah C Katzelnick; Henry Puerta-Guardo; Ramesh Jadi; Samuel Schildhauer; Piyada Supasa; Sirijitt Vasanawathana; Prida Malasit; Juthathip Mongkolsapaya; Aruna D de Silva; Hasitha Tissera; Angel Balmaseda; Gavin Screaton; Aravinda M de Silva; Eva Harris
Journal:  J Infect Dis       Date:  2018-07-13       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.